Sep 14, 2018
Kanazawa University Research: Mechanism of Biological Noise Cancellation Revealed
Sep 06, 2018
Maine-Based Door to Door Doctors Deploys Q2i's OARS Technology to Support Patients Recovering from Opioid Use Disorder
Aug 22, 2018
iHuman Team at ShanghaiTech University Deciphers the First Human Frizzled Receptor Structure
Aug 15, 2018
Peptide Logic Awarded A $ 2.9 Million SBIR Phase II Grant To Develop Peripherally-Restricted And Long-Acting Kappa-Opioid Receptor (LA-KOR) Agonists For Moderate-To-Severe Pain
Aug 01, 2018
The global kidney cancer drugs market size is expected to be valued at USD 6.3 billion by 2022
Jul 16, 2018
Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid use Disorder
Jun 27, 2018
Beacon Discovery Announces Partnership With Escient Pharmaceuticals And Expansion Of Its San Diego Facility
Jun 22, 2018
Broken Shuttle May Hinder Learning across Several Brain Disorders
Jun 18, 2018
Zubsolv® Now Launched in the EU, Which Triggers a EUR 3m Milestone Payment to Orexo
May 30, 2018
Chrysanthy Tsakopoulos Demos Named President & CEO Of AKT Investments Inc., Northern California's Largest Land Development Company
May 28, 2018
Braeburn Resubmits New Drug Application for CAM2038 for Opioid Use Disorder
May 14, 2018
Aquestive Therapeutics Settles Patent Infringement Case with Par Pharmaceuticals
Apr 16, 2018
Alkermes Announces FDA Acceptance for Review of New Drug Application for ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder
Apr 10, 2018
Tuberous Sclerosis Alliance salutes FDA approval of Afinitor® DISPERZ (everolimus) as the first adjunctive treatment approved in US for patients aged 2 years and older with tuberous sclerosis complex (TSC)-associated partial-onset seizures
Apr 09, 2018
Supporting Cells in the Heart Contribute to Cardiac Disease
Apr 02, 2018
Alkermes Receives Refusal to File Letter From FDA for ALKS 5461
Mar 29, 2018
Global Cancer Janus Kinase Inhibitors Market Opportunity & Clinical Trial Insight 2023
Mar 26, 2018
Titan Pharmaceuticals Schedules Conference Call To Review Fourth Quarter And Full Year 2017 Financial Results
Mar 21, 2018
Titan Executes Agreement For Acquisition By Molteni Of Probuphine® In Europe And Other Select Territories
Mar 09, 2018
Global mTOR Inhibitors Therapeutics Pipeline Analysis Report 2017